Changes in membrane cholesterol affect caveolin-1 localization and ICC-pacing in mouse jejunum.
D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D021941:Caveolae / Q000378:metabolism* / Q000648:ultrastructure; D051242:Caveolin 1; D022461:Caveolins / Q000378:metabolism*; D002784:Cholesterol / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D018679:Cholinergic Agonists / Q000494:pharmacology; D003505:Cyclodextrins / Q000494:pharmacology; D004558:Electric Stimulation; D005769:Gastrointestinal Motility / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D007583:Jejunum / Q000294:innervation* / Q000378:metabolism* / Q000648:ultrastructure; D051379:Mice; D008807:Mice, Inbred BALB C; D009130:Muscle, Smooth / Q000378:metabolism; D009197:Myenteric Plexus / Q000166:cytology / Q000502:physiology*; D009474:Neurons / Q000502:physiology; D010507:Periodicity; D012995:Solubility; D014018:Tissue Distribution / Q000187:drug effects; D047392:beta-Cyclodextrins
C495541:Cav1 protein, mouse; D051242:Caveolin 1; D022461:Caveolins; D018679:Cholinergic Agonists; D003505:Cyclodextrins; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin; D002217:Carbachol; D002784:Cholesterol